Syngene Int. - Syngene International Share Price

Syngene Int. Share Recommendations

Syngene Int. Financials

Syngene Int. Technicals

Syngene Int. Peer Comparison

Syngene Int. Shareholding Pattern

Syngene Int. MF Ownership

• Nippon India Small Cap Direct-G

  Equity: Small Cap

  4

  • 254.11

    Amount Invested (in Cr.)

  • 0.38%

    % of AUM

  • 17.47

    % Change (MoM basis)

• Mirae Asset Focused Direct-G

  Equity: Flexi Cap

  2

  • 246.03

    Amount Invested (in Cr.)

  • 3.16678511%

    % of AUM

  • 14.45

    % Change (MoM basis)

• ICICI Pru ELSS Tax Saver Direct-G

  Equity: ELSS

  3

  • 234.82

    Amount Invested (in Cr.)

  • 1.62786268%

    % of AUM

  • 1.31

    % Change (MoM basis)

Syngene Int. Corporate Actions

About Syngene Int.

Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 25,308.62 Crore) operating in Pharmaceuticals sector. Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue and Scrap for the year ending 31-Mar-2025.For the quarter ended 30-06-2025, the company has reported a Consolidated Total Income of Rs 892.20 Crore, down 13.96 % from last quarter Total Income of Rs 1,036.90 Crore and up 10.45 % from last year same quarter Total Income of Rs 807.80 Crore. Company has reported net profit after tax of Rs 86.70 Crore in latest quarter.The company’s top management includes Ms.Kiran Mazumdar Shaw, Mr.Peter Bains, Prof.Catherine Rosenberg, Dr.Kush Parmar, Mr.Manja Boerman, Mr.Nilanjan Roy, Ms.Sharmila Abhay Karve, Dr.Vijay Kuchroo, Ms.Vinita Bali, Mr.Deepak Jain, Mr.Priyadarshini Mahapatra. Company has B S R & Co. LLP as its auditors. As on 30-06-2025, the company has a total of 40.29 Crore shares outstanding.Syngene Int. Share Price Today is Rs. 640.40. On previous day, the Syngene Int. Share Price (NSE) closed at Rs. 625.65, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 30th Jun, 2025, the promoter held 52.68% of the stake in Syngene Int. shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Syngene Int. stocks was 16.51% as compared to 19.47% in Mar 2025 with decrease of 2.96%. The domestic institutional investors (DII) holdings on 30th Jun, 2025 was 24.04% as compared to 21.5% in Mar 2025 with increase of 2.54%. Out of the total DII holdings in Syngene Int. shares 20.7% was held by mutual funds. The rest including public held is 6.77%. Syngene Int. stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Syngene Int. Dividend: Ever since 1993, Syngene Int. dividends has been paid out around 9 times. As on 16 Oct, 2025, 03:58 PM IST, The overall dividend yield for Syngene Int. stands at 0.2%. The last dividend paid was on June 27, 2025 (Rs. 1.25). The Earnings Per Share (EPS) for quarter ending 30th Jun 2025 is Rs. 12.59.

Syngene Int. Bonus: The most recent bonus issue had been in year June 11, 2019 around 6 years ago at 1 : 1 ratio. The first bonus issue was announced in Apr 2019.

Stock Forecast:
After showing 892.2 Cr. of sales and 13.96% of quarterly net loss, there have been multiple ups and downs in the Syngene Int. stock prices in the past few weeks. For example, Syngene Int. stock price on 8th of October 2025 was around Rs. 630.65. Syngene Int. share price now stands at an average of Rs. 640.40. Judging by last week's performance, stock is in down trend.

Syngene Int. has a median target price of Rs. 709.38 in 12 months by 8 analysts. They have provided a high estimate of Rs. 840.0 and low estimate of Rs. 570.0 for Syngene Int. share.

Historical Prices and Performance:
Syngene Int., incorporated in 1993 is a Mid Cap company (with a market cap of Rs. 25308.62) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Syngene Int. stock was 10.49%, 11.97%, 12.83%, 12.0% and 14.35% respectively.
The Syngene Int. share gave a 3 year return of 14.03% as compared to Nifty 50 which gave a return of 47.35%.
Syngene Int. announced 12.5% final dividend on June 27, 2025.

Key Metrics:
PE Ratio of Syngene Int. is 49.7
Prices/Sales Ratio of Syngene Int. is 8.02
Price/Book Ratio of Syngene Int. is 5.33

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Syngene Int., major competitors and peers include Ipca Labs, Gland Pharma, Ajanta Pharma and J B Chemicals. As of Mar 2025, the dividend yield of Syngene Int. stands at 0.2% while Ipca Labs, Gland Pharma, Ajanta Pharma and J B Chemicals stand at 0.31%, 0.0%, 1.16% and 0.93% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 49.7 and 5.33 respectively.

Recommendations:
The current total number of analysts covering the stock stands at 8, Three months ago this number stood at 9. Out of total, 2 analyst have a'Strong Buy' reco, 3 analyst have a'Buy' reco, 1 analyst have a'Hold' reco, 2 analyst have a'Sell' reco.

Mean recommendations by 8 analyst stand at'Buy'.

Leadership of Syngene Int. :
Alex Del Priore is Senior Vice President
Andrew Webster is Chief Human Resource Officer
Priyadarshini Mahapatra is Co. Secretary & Compl. Officer
Kenneth Barr is Senior Vice President
Alok Mehrotra is Chief Quality Officer
Caroline Hempstead is Head
Deepak Jain is Chief Financial Officer
Pramuch Goel is Head
Jayashree Aiyar is Chief Scientific Officer
Kiran Mazumdar Shaw is Non Executive Chairman
Peter Bains is Managing Director & CEO
Catherine Rosenberg is Non Executive Director
Vinita Bali is Lead Independent Director
Nilanjan Roy is Independent Director
Kush Parmar is Independent Director
Sharmila Abhay Karve is Independent Director
Vijay Kuchroo is Independent Director
Manja Boerman is Independent Director


Show More